Skip to main content
PLOS One logoLink to PLOS One
. 2021 Jul 22;16(7):e0254953. doi: 10.1371/journal.pone.0254953

Diagnostic efficiency and validity of the DSM-oriented Child Behavior Checklist and Youth Self-Report scales in a clinical sample of Swedish youth

Gudmundur Skarphedinsson 1,*, Håkan Jarbin 2,3, Markus Andersson 2,3, Tord Ivarsson 4
Editor: Thomas M Olino5
PMCID: PMC8297893  PMID: 34293000

Abstract

The Child Behavior Checklist (CBCL) and Youth Self-Report (YSR) are widely used measures of psychiatric symptoms and lately also adapted to the DSM. The incremental validity of adding the scales to each other has not been studied. We validated the DSM subscales for affective, anxiety, attention deficit/hyperactivity (ADHD), oppositional defiant (ODD), conduct problems (CD), and obsessive-compulsive disorder (OCD) in consecutively referred child and adolescent psychiatric outpatients (n = 267) against LEAD DSM-IV diagnoses based on the K-SADS-PL and subsequent clinical work-up. Receiver operating characteristic analyses showed that the diagnostic efficiency for most scales were moderate with an area under the curve (AUC) between 0.70 and 0.90 except for CBCL CD, which had high accuracy (AUC>0.90) in line with previous studies showing the acceptable utility of the CBCL DSM scales and the YSR affective, anxiety, and CD scales, while YSR ODD and OCD had low accuracy (AUC<0.70). The findings mostly reveal incremental validity (using logistic regression analyses) for adding the adolescent to the parent version (or vice versa). Youth and parent ratings contributed equally to predict depression and anxiety disorders, while parent ratings were a stronger predictor for ADHD. However, the youth ADHD rating also contributed. Adding young people as informants for ODD and OCD or adding the parent for CD did not improve accuracy. The findings for depression, anxiety disorders, and ADHD support using more than one informant when conducting screening in a clinical context.

Introduction

Recent systematic reviews report that at any given year approximately 13–25% of youth suffer from mental disorders that cause significant functional impairment in important domains of everyday life such as family, school, and socializing with peers [1, 2]. This brings about high costs and suffering for the individual, family, and society as a whole [3, 4] warranting efficient and effective assessment and treatment for these young people. However, only a small proportion of youth with mental disorders receive adequate treatment [5]. This is especially true for internalizing disorders which are greatly underdiagnosed and undertreated [69]. Thus, the need to identify and treat pediatric mental disorders is important and may potentially reduce the risk of impairment, severity, and recurrence of psychopathology in the future [6, 10, 11].

Standardized diagnostic interviews (SDIs) are considered to be the gold standard [12]. Brief continuous psychometric measures are more time-efficient and thus less expensive. They can be suitable for screening or as part of clinical intake procedures to capture a wide range of symptoms in a cost-efficient fashion [13]. However, it is important to evaluate the diagnostic efficiency of screening instruments using representative samples, such as consecutive treatment seeking children [14, 15].

Collecting and combining data from multiple informants (e.g., parents and children) can increase the accuracy of screening and is recommended as informant discrepancy is common [1621] and particularly for subjective symptoms and behavior outside the home [22, 23].

The Child Behavior Checklist (CBCL) and Youth Self-Report (YSR) are widely used measures of psychiatric symptoms in young people, measuring a range of problem areas [24]. They are often used as part of clinical intake procedures and can screen for psychiatric disorders without any additional cost for the clinic or the family. The syndrome scales of the CBCL/YSR derived by factor analysis have only shown modest concordance with the Diagnostic and Statistical Manual of Mental Disorders (DSM) [2528]. For instance, as each syndrome scale is related to multiple DSM disorders (e.g., the anxious/depressed component is related to both depressive disorders and anxiety disorders), making it impossible to tease apart whether a child’s symptoms are congruent with depressive or anxiety disorders or both [28]. This lack of concordance is suboptimal as treatment options are based on DSM or International Classification of Diseases (ICD) diagnoses.

The authors of the CBCL/YSR have attempted to overcome this limitation by developing DSM-oriented scales (DOSs) based on expert consensus, choosing pre-existing items corresponding with the DSM criteria. This has resulted in the following DOSs: affective, anxiety, somatic, attention deficit/hyperactivity (ADHD), oppositional defiant (ODD), conduct problems (CD), and obsessive-compulsive disorder (OCD). Several studies have investigated the concurrent validity of the DOSs in clinical samples and compared this with syndrome scales. Ebesutani and colleagues [29, 30] showed that DOSs are not superior to the original syndrome scales, while Bellina [31] showed weaker correspondence between the DOS and DSM diagnoses compared with syndrome scales except for the ADHD scale, which outperformed the older attention problems scale. Further, Aebi [32] showed better correspondence between the affective DOS and DSM-IV diagnosis of major depressive disorder than the older syndrome scales. Most studies have reported acceptable correspondence between the affective DOS and a depressive disorder diagnosis [3336], the anxiety DOS and anxiety disorders [3436], and the ADHD, ODD, and CD scales and their corresponding disorders [35, 36]. Some evidence also exists for the OCD scale but not in purely clinical samples [37, 38].

However, we are not aware of any existing study that has combined data from multiple informants to evaluate increased accuracy of the DOS. The present study addresses the lack of data on the diagnostic efficiency of the DOS when combining data from multiple informants. The aim of the current study was to evaluate the concurrent and discriminant validity of the DOS in a large consecutive help-seeking sample at CAP clinics by comparing diagnosis-specific DOS scores between children with and without the diagnosis-specific disorder, and by using receiver operating characteristic (ROC) to examine the screening efficiency of the DOS. Secondary aims were to examine gender differences in mean scores as discovered in our previous papers using same data [18, 19] and to evaluate the incremental validity of the DOS by combining data from multiple informants.

Method

Participants

In all, we included 307 CAP outpatients who consecutively sought treatment at four CAP clinics in southern Sweden from January 2010 to March 2013. Further information can be retrieved from our previous publications on this sample [12, 18, 19]. Briefly, our exclusion criterion was insufficient proficiency in Swedish by the patient or the parent. Forty cases were discarded due to protocol violations in the Schedule for Affective Disorders and Schizophrenia for School-Age Children–Present and Lifetime Version (K-SADS-PL) interview. One clinician used leading questions or did not ask both parent and child questions about all symptom areas and another clinician failed to sufficiently report data. The data from the remaining 267 cases are reported. These cases had a mean age of 12.1 (SD 3.2, range 6.1–17.8) years. The proportion of children 6–12 years was 57.7% (n = 154). There were slightly more boys (n = 150, 56.2%) than girls. The CBCL was filled out by 263 (98.5%) parents of these patients. Mothers’ CBCL data were used in the parental CBCL in 240 (89.9%) cases; fathers’ ratings were used only when those were the only data available (23 cases, 8.6%). The YSR was filled out by 139 (52.1%) young people, as it was only distributed to patients aged 11–17 years. Both YSR and CBCL ratings were available for 137 (51.3%) patients.

Measures and procedures

A comprehensive description of measures and procedures can be found in a previous report [12]. Briefly, the semi-structured interview K-SADS-PL was used by resident MDs following a training program. The K-SADS interviews with both parents and patients yielded DSM-IV diagnoses, which were then further evaluated by using a Longitudinal Expert All Data (LEAD) process commonly viewed as the gold standard for evaluating semi-structured interviews. This process considers all information brought in through diagnostic procedures, the level of impairment, and the treatment outcome across a suitable period [3942]. To be eligible for LEAD, the record should have covered at least six months of follow-up from the K-SADS-PL and included a minimum of three further visits or significant information from a teacher or an assessment by a senior clinician. In the LEAD work, the assessors had access to the K-SADS-PL interview as well as subsequent information from the medical records. All these data were retrieved by using a structured form. Thus, the re-evaluation of the K-SADS diagnoses was systematic and included oral reports and report forms from teachers and other informants, psychological assessments, and the outcome of pharmacological and psychological treatment. The observation time that yielded new diagnostic information was 1.2 (SD 0.6) years with a range of 0.1–3.1 years. For further information about the reliability of this process, see [12]. The LEAD procedure and clinical records were blind to the CBCL and YSR. The Ethical Review Board at Lund University approved the study. Patients aged 15 years and above and parents consented to the study in writing.

ASEBA–Achenbach System and Empirically Based Assessment

The Child Behavior Checklist (CBCL) for ages 6–18 [24] is a 120-item, parent-rated questionnaire designed to assess children’s social competence and mental health problems. The equivalent self-rated questionnaire is The Youth Self-Report (YSR) for ages 11–18. Items on the two lists are rated on a 0–2 rating scale: 0 = not true; 1 = somewhat or sometimes true; 2 = very or often true. Achenbach and Rescorla (2001) constructed a new scoring system for the CBCL and YSR scales, based on the DSM diagnostic criteria, the DSM-oriented scales, which will be used in the current study. The scales are affective problems, anxiety problems, attention-deficit/hyperactivity (ADHD) problems, oppositional defiant problems (ODD), and conduct problems (CD). We also examined OCD problems [38]. The internal consistency was as followed: affective (CBCL internal consistency (α = 0.82, YSR α = 0.80), anxiety (CBCL α = 0.82, YSR α = 0.73), ADHD (CBCL α = 0.84, YSR α = 0.76), ODD (CBCL α = 0.84, YSR α = 0.61), CD (CBCL α = 0.81, YSR α = 0.82), and OCD (CBCL α = 0.77, YSR α = 0.76).

Statistics

T-tests were conducted to examine gender and diagnostic group differences on the DOS mean scores. Receiver operating characteristics (ROC) analyses were conducted to examine the concurrent validity of the CBCL/YSR DOSs versus a LEAD diagnosis [14, 43]. Generally, the area under the curve (AUC) is judged to represent low accuracy between 0.50 and 0.70, moderate accuracy between 0.70 and 0.90, and high accuracy above 0.90 [44]. The agreements between LEAD diagnoses and cut-off scores for the CBCL/YSR DOSs were also evaluated by using the Kappa statistic: poor agreement = less than 0.20; fair agreement = 0.20–0.40; moderate agreement = 0.40–0.60; good agreement = 0.60–0.80; and very good agreement = 0.80–1.00 [45]. We also conducted series of multivariate logistic regression analyses to evaluate the concurrent and discriminant validity of the CBCL/YSR DOSs. In addition, sequential logistic regression analyses were conducted to examine whether adding an informant (child or parent) would increase how accurately children with a disorder could be identified based on the relevant CBCL/YSR DOS. Sequential logistic regression was only used for participants 11 years or older since YSR was not administered to younger participants.

Results

Sample characteristics

The frequency of psychiatric disorders for the total sample and by gender is displayed in Table 1. The most prevalent disorders were ADHD (53%), anxiety disorders (36%), and depressive disorders (29%) while least prevalent were OCD (5%), and conduct disorders (4%).

Table 1. The frequency of psychiatric disorders in the outpatient sample (n = 267).

Mental disorders Boys Girls Total
n % n % n %
Any depressive disorder 40 26.7 40 34.2 80 30.0
Anxiety disorders 48 32.0 48 41.0 96 36.0
ADHD 91 60.7 51 43.6 142 53.2
ODD 34 22.7 28 23.9 62 23.2
CD 9 6.0 3 2.6 12 4.5
OCD 7 4.7 5 4.3 12 4.5

Any depressive disorder: Major Depressive Disorder, Dysthymic Disorder, or Depressive Disorder NOS.

Anxiety disorders: Generalized Anxiety Disorder, Separation Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia, and Specific Phobia.

Disorder-specific and gender differences

Table 2 displays the means and standard deviations (SDs) for the CBCL and YSR for all DOSs. Participants diagnosed with a specific disorder (e.g., any depressive disorder) scored significantly higher on the corresponding DOS (e.g., affective) compared with participants without a specific disorder. However, we did not find any significant differences between participants with or without a diagnosis for YSR ODD and OCD subscale. We observed gender-specific differences for the CBCL ADHD scale, where parents scored significantly higher for boys than for girls. On the contrary, girls scored significantly higher than boys on the YSR affective, anxiety, and OCD scales.

Table 2. Means, standard deviations, and independent t-test as per diagnostic group for CBCL and YSR and boys and girls.

Disorder Gender
Scale/subscale All M (SD) Diagnosis-specific disorder present M (SD) n Disorder absent M (SD) n t-test Boys M (SD) Girls M (SD) t-test
CBCL n = 263 n = 146 n = 117
Affective 5.95 (3.40) 8.86 (4.61) 77 4.75 (3.96) 186 -7.283*** 5.73 (4,25) 6.24 (4,91) -0.908
Anxiety 4.08 (3.30) 5.85 (3.31) 95 3.08 (2.86) 168 -7.125*** 3.77 (3,27) 4.47 (3,32) -1.705
ADHD 6.39 (3.91) 8.30 (3.46) 139 4.24 (3.23) 124 -9.807*** 6.91 (3,83) 5.74 (3,93) 2.445*
ODD 4.80 (2.82) 7.05 (2.06) 61 4.12 (2.67) 202 -9.030*** 4.84 (2,92) 4.76 (2,71) 0.213
CD 5.60 (4.85) 14.45 (4.16) 11 5.21 (4.51) 252 -6.678*** 6.09 (4,90) 4.99 (4,74) 1.838
OCD 3.06 (2.86) 8.58 (3.70) 12 2.80 (2.53) 252 -7.547*** 2.87 (2,87) 3.31 (2,83) -1.239
YSR n = 139 n = 66 n = 73
Affective 7.73 (5.07) 10.20 (5.25) 61 5.81 (4.00) 78 -5.416*** 6.67 (4,84) 8.70 (5,11) -2.401*
Anxiety 4.53 (3.24) 6.19 (3.47) 48 3.65 (2.74) 91 -4.727*** 3.68 (3,15) 5.29 (3,14) -3.006**
ADHD 6.09 (3.23) 7.42 (3.24) 60 5.09 (2.86) 79 -4.488*** 6.05 (3,32) 6.14 (3,17) -0.166
ODD 4.71 (2.18) 5.27 (1.76) 26 4.58 (2.25) 113 -1.452 4.53 (2,14) 4.88 (2,22) -0.936
CD 4.94 (4.13) 11.00 (5.90) 8 4.57 (3.72) 131 -4.576*** 5.03 (4,26) 4.86 (4,03) 0.238
OCD 4.58 (3.40) 6.75 (4.37) 8 4.45 (3.31) 131 -1.872 3.79 (2,99) 5.30 (3,61) -2.702**

CBCL subscales explanations.

Significant differences between disorder diagnosed and gender: *** = p < .001, ** = p < .01 and * = p < .05.

CBCL = Child Behavior Checklist.

YSR = Youth-Self Report.

Diagnostic efficiency

First, we conducted a series of ROC analyses to evaluate how efficiently the DOSs predicted the presence of a corresponding LEAD diagnosis (Table 3). All predictions except YSR ODD and OCD were significant. We observed that CBCL CD predicted a diagnosis of CD with high accuracy. We observed moderate accuracy for the other DOSs in predicting the presence of their corresponding LEAD diagnoses.

Table 3. Psychometric properties for the CBCL and YSR versus a LEAD diagnosis.

AUC (95% CI) P Cut-off Sensitivity % Specificity % Kappa
CBCL Affective -> Any depression .77 (.71, .82) < .001 ≥7 75 70 .40
CBCL Anxiety–> Any anxiety .75 (.69, .80) < .001 ≥6 52 82 .35
CBCL ADHD -> ADHD .81 (.75, .85) < .001 ≥6 81 70 .51
CBCL ODD -> ODD .80 (.75, .85) < .001 ≥8 52 87 .40
CBCL CD -> CD .93 (.89, .96) < .001 ≥14 55 95 .38
CBCL OCD -> OCD .89 (.85, .92) < .001 ≥8 75 94 .48
YSR Affective -> Any depression .74 (.66, .81) < .001 ≥9 67 76 .43
YSR Anxiety–> Any anxiety .72 (.63, .78) < .001 ≥6 60 75 .34
YSR ADHD -> ADHD .71 (.63, .78) < .001 ≥7 65 70 .34
YSR ODD -> ODD .61 (.52, .69) .060 ≥6 54 70 .18
YSR CD -> CD .84 (.77, .90) < .001 ≥9 75 85 .29
YSR OCD -> OCD .66 (.57, .74) .174 ≥9 50 85 .19

AUC = Area under the curve.

CBCL = Child Behavior Checklist.

YSR = Youth Self-Report.

Second, we selected the most efficient cut-off scores to equally minimize the false-positive and false-negative results by establishing maximizing efficiency κ(0.5) [29, 30]. Then, we evaluated the sensitivity and specificity of these cut-off scores (Table 3). For the CBCL and YSR affective scales, the Kappa [κ(0.5)] showed moderate agreement with their corresponding LEAD (any depressive disorder) diagnoses. The same was true for CBCL ADHD and OCD. All the other agreements were fair, except for YSR ODD and OCD, which showed poor agreement. Sensitivity ranged from 50% for YSR OCD to 81% for CBCL ADHD. The corresponding specificity ranged from 70% for the CBCL affective DOS, CBCL/YSR ADHD, and YSR ODD to 95% for CBCL CD (Table 3). More detailed results of the ROCs can be found in supplemental tables (see S1 File) with a presentation of each cutoff from 90% sensitivity to 90% specificity with kappa, positive and negative diagnostic likelihood ratio, and positive and negative predictive values.

Concurrent and discriminant validity

We also conducted a series of multivariate logistic regression analyses to evaluate the concurrent and discriminant validity of each subscale. Thus, we aimed to verify whether only the corresponding subscale of the DOS is associated with particular LEAD diagnoses compared to the other subscales (Table 4). The odds ratios (ORs) showed that the CBCL’s affective, anxiety, and ADHD, and ODD scales all predict the presence of their corresponding LEAD diagnoses. However, the ADHD DOS also significantly but negatively predicted the presence of a LEAD depression diagnosis. Likewise, the CBCL affective scale also significantly negatively predicted the presence of a LEAD ADHD diagnosis.

Table 4. Convergent/Divergent validity of the CBCL and YSR DOS versus LEAD diagnoses using multivariate logistic regression where the odds ratio (OR) refers to the likelihood of a diagnosis for every additional score point on each DOS.

CBCL Depression OR (95% CI) p Anxiety OR (95% CI) p ADHD OR (95% CI) p ODD OR (95% CI) p
χ2, p 73.044, p < .001 69.678 p < .001 96.418 p < .001 64.383 p < .001
CBCL Depression 1.32 (1.20, 1.46) < .001 0.99 (.91, 1.07) .737 0.91 (0.83, 0.99) .024 0.93 (0.84, 1.02) .124
CBCL Anxiety 0.87 (0.75, 1.00) .054 1.52 (1.31, 1.77) < .001 0.89 (0.77, 1.02) .104 0.90 (0.77, 1.06) .217
ADHD 0.81 (0.73, 0.91) < .001 0.92 (0.83, 1.01) .0.84 1.46 (1.30, 1.64) < .001 0.96 (0.86, 1.07) .469
ODD 1.00 (0.84, 1.19) .997 0.99 (0.84, 1.17) .906 1.11 (0.94, 1.31) .223 1.67 (1.34, 2.08) < .001
CD 1.01 (0.90, 1.12) .905 0.14 (0.82, 1.02) .109 0.95 (0.86, 1.06) .354 1.03 (0.92, 1.14) .641
OCD 1.11 (0.94, 1.30) .223 0.85 (0.73, 1.00) .045 1.06 (0.90, 1.24) .501 1.06 (0.88, 1.28) .519
YSR Depression OR (95% CI) P Anxiety OR (95% CI) p ADHD OR (95% CI) p ODD OR (95% CI) p
χ2, p 50.829, p < .001 42.173 p < .001 37.316 p < .001 13.802 p = .032
YSR Depression 1.40 (1.21, 1.62) < .001 1.05 (0.92, 1.19) .472 0.83 (0.73, 0.95) .005 0.91 (0.78, 1.05) .196
YSR Anxiety 0.91 (0.75, 1.10) .334 1.42 (1.16, 1.75) .001 1.10 (0.91, 1.33) .329 1.06 (0.85, 1.32) .630
ADHD 0.72 (0.59, 0.88) .001 0.93 (.78, 1.11) .419 1.45 (1.22, 1.74) < .001 1.08 (0.90, 1.28) .415
ODD 0.72 (0.55, 0.95) .018 .95 (.73, 1.25) .722 1.01 (0.79, 1.30) .914 1.21 (0.90, 1.63) .202
CD 1.21 (1.04, 1.40) .011 0.79 (0.67, 0.95) .011 1.05 (0.92, 1.21) .481 1.03 (0.88, 1.20) .730
OCD 1.04 (0.86, 1.26) .681 0.96 (0.79, 1.16) .671 0.91 (0.75, 1.09) .289 0.82 (0.65, 1.03) .083

CBCL = Child Behavior Checklist.

YSR = Youth Self-Report.

DOS = DSM oriented scale.

The YSR affective, anxiety, and ADHD DOSs predicted their corresponding LEAD diagnoses. However, YSR ODD did not predict the presence of the ODD diagnosis. Like the CBCL findings, we observed that the YSR ADHD and CD DOSs negatively predicted LEAD (any depression). Similarly, the YSR CD predicted LEAD anxiety. We did not analyze the data for CD or OCD due to too few diagnoses.

Incremental validity

We evaluated the possible benefit of adding the DOS child report (YSR) to the parent report (CBCL) and vice versa in predicting LEAD diagnoses. We used a sequential logistic regression analysis to evaluate whether the DOSs would predict the presence of a depressive disorder, anxiety disorder, ADHD, ODD, CD, and OCD. First, we entered the parent report and then added the adolescent report. Second, we started with the adolescent report and then added the parent report. In this way, we evaluated the unique contribution of each informant to the other (Table 5). We found good goodness-of-fit values for all analyses (Hosmer–Lemeshow p>0.05). For the affective scale, in the single variable models, both the YSR and the CBCL DOSs predicted the presence of depressive disorders (OR = 6.54 for YSR and OR = 5.29 for CBCL), explaining 24% of the variance (R2). We observed significant benefits of adding the CBCL to the YSR (Δχ2 = 16.172, p<0.001) and vice versa (Δχ2 = 16.113, p<0.001). In the final model, both the CBCL and the YSR predicted the presence of depressive disorders (Table 5), explaining 36% of the variance. The DOS for anxiety predicted the presence of any anxiety disorder (OR = 4.88 for CBCL and OR = 4.56 for YSR), explaining 16% of the variance in the single variable models. Both scales demonstrated significant benefits when added to each other (Δχ2 = 9.422, p<0.05 for adding the CBCL and Δχ2 = 9.017, p<0.05 for adding the YSR) explaining 24% of the variance. The DOS for ADHD also predicted the presence of ADHD (OR = 8.18 for CBCL and OR = 4.39 for YSR explaining 28% and 16% of variance) in single variable models. Both scales showed significant benefits of adding an informant (Δχ2 = 24.40, p<0.001 for adding the CBCL and Δχ2 = 9.19, p<0.05 for adding the YSR) explaining 35% of the variance. We observed a significant OR (OR = 7.41 for CBCL and OR = 2.76 for YSR) when predicting ODD in the one informant (variable) model. However, only the CBCL carried significant benefits when added to the YSR (Δχ2 = 11.435, p<0.001). Both scales had significant ORs when predicting the presence of CD (OR = 15.13 for CBCL and OR = 16.35 for YSR), but only the YSR carried significant benefits when added to the CBCL (Δχ2 = 4.91, p<0.05). Both scales predicted the presence of OCD (OR = 52.29 for CBCL and OR = 5.79 for YSR) but only the CBCL carried significant benefits when added to the YSR (Δχ2 = 17.74, p<0.001).

Table 5. Sequential logistic regression to test the effects of child and parent report on the DOS scales (using the most optimal cut-off scores) for the prediction of LEAD diagnoses.

LEAD diagnosis Scale OR (95%) Wald Full model χ2 Full model adding an extra report χ2 R2
Any depression Only one informant CBCL 6.98 (3.14, 15.51) 22.762*** 26.579*** .24
YSR 6.54 (3.08, 13.87) 23.946*** 26.520*** .24
Any depression Adding another informant Add parent- to youth-report 5.29 (2.27, 12.35) 14.855*** 42.692*** Δ16.172*** .36
Add youth—to parent-report 4.97 (2.22, 11.09) 15.329*** 42.692*** Δ16.113***
Any anxiety Only one informant CBCL 4.88 (2.34, 10.63) 15.904*** 16.680*** .16
YSR 4.56 (2.14, 9.69) 15.481*** 16.276*** .16
Any anxiety Adding another informant Add parent- to youth-report 3.61 (1.59, 8.20) 9.354* 25.698*** Δ9.422* .24
Add youth—to parent-report 3.39 (1.52, 7.52) 8.970** 25.698*** Δ9.017*
ADHD Only one informant CBCL 8.18 (3.76, 17.79) 28.147*** 32.399*** .28
YSR 4.39 (2.13, 9.04) 16.099*** 17.186*** .16
ADHD Adding another informant Add parent- to youth-report 6.89 (3.08, 15.41) 22.133*** 41.587*** Δ24.401*** .35
Add youth—to parent-report 3.39 (1.52, 7.52) 8.974*** 41.587*** Δ9.188*
ODD Only one informant CBCL 7.41 (2.69, 20.41) 14.990*** 14.736*** .16
YSR 2.76 (1.15, 6.59) 5.200* 5.206* .06
ODD Adding another informant Add parent- to youth-report 6.17 (2.17, 17.56) 11.649*** 16.641*** Δ11.435*** .18
Add youth—to parent-report 1.96 (0.76, 5.04) 1.942 16.641*** Δ1.904
CD Only one informant CBCL 15.13 (3.18, 71.96) 11.652*** 10.289*** .20
YSR 16.35 (3.08, 86.84) 10.757*** 12.852*** .25
CD Adding another informant Add parent- to youth-report 4.10 (0.66, 25.38) 2.299 15.197*** Δ2.345 .29
Add youth—to parent-report 8.83 (1.29, 60.39) 4.929* 15.197*** Δ4.908*
OCD Only one informant CBCL 52.29 (8.89, 307.69) 19.145*** 22.551*** .42
YSR 5.79 (1.33, 25.15) 5.490* 5.061* .10
OCD Adding another informant Add parent- to youth-report 43.42 (6.49, 290.34) 15.128*** 22.800*** Δ17.739*** .43
Add youth—to parent-report 1.62 (0.25, 10.57) 0.254 22.800*** Δ0.25

CBCL (parent-report) = Child Behavior Checklist.

YSR (youth report) = Youth Self-Report.

Only one informant = univariate models.

Adding another informant = multivariate model.

Discussion

In the current study, we evaluated the concurrent and incremental validity of the CBCL and YSR DOSs with several DSMs internalizing and externalizing diagnoses based on the LEAD gold standard [12, 39]. This is the first study to evaluate the incremental validity of the CBCL added to YSR DOSs and vice versa.

In this sample of newly referred child and adolescent psychiatric outpatients, the concurrent validity of the parent reports (CBCL DOSs) showed moderate accuracy in predicting the presence of the corresponding disorder (AUC 0.75–0.89) while CD DOS predicted the presence of CD in the sample with high accuracy (AUC = 0.93). The child reports (YSR DOS) predicted the corresponding LEAD-disorder with moderate accuracy. However, the accuracy of the youth ODD and OCD DOSs was low and not significant as opposed to the corresponding parent report. The scales also showed incremental validity when added to each other. However, adding the child as an informant did not increase diagnostic efficiency for ODD and OCD.

The low accuracy for the YSR ODD subscale is at odds with previous studies examining youth in the general population [30] or incarcerated adolescents [46]. Further, the YSR ODD scale had weak internal consistency (α = 0.61), supporting the inadequacy of this subscale in a clinical population. The diagnostic efficiency of the self-report (YSR) OCD scale has not been investigated previously. The low accuracy of the YSR OCD subscale is in line with studies of other self-report instruments for obsessive and compulsive symptoms in young people [47].

Cut-off values were chosen based on maximizing efficiency. We found moderate agreement between our cut-offs and LEAD diagnoses for the affective, ADHD, ODD, and OCD CBCLs (Kappa 0.40–0.51) and just slightly below moderate agreement for anxiety and CD (0.35, 0.38). All these cut-off values rendered acceptable sensitivity and specificity (e.g., affective scale: 75% sensitivity and 70% specificity) for screening in a clinical setting. The Kappa for the YSR scales showed moderate agreement with any depression but only fair agreement with anxiety, ADHD, and CD. However, we found poor agreement between the YSR OCD and ODD subscale and the corresponding LEAD diagnosis, reflecting the low AUC levels. Thus, most cut-off scores (especially the affective DOS (for both CBCL and YSR) and CBCL ADHD and OCD scales from the ROC analyses (based on the point where both sensitivity and specificity are optimal) can be used with confidence given that the sample is similar to the sample in our analyses.

We found clear evidence for both concurrent and discriminant validity of the DOSs for anxiety (CBCL and YSR) and for ODD (CBCL). Surprisingly, both affective and ADHD subscales (CBCL and YSR) predicted but also inversely predicted the presence of any depression or any ADHD. It is remarkable that both the CBCL and the YSR DOSs indicated a lower chance of depression with a high score on ADHD and vice versa despite the established comorbidity between these disorders. However, in this enriched clinical sample, patients with depression had clinically important comorbidity with ADHD but still a significantly lower rate of ADHD than those without depression (35% vs. 61%, p<0.001). We are not aware of any previous studies that have investigated the divergent validity of the DOS in a similar manner. The prevalence of both ADHD and any depressive disorder was high in this sample and the majority of the young people had at least one comorbid disorder [12], thus reflecting the clinical situation in a true manner and making screening and differential diagnostics more complicated.

Overall, we found good evidence that adding the parent as an informant, or vice versa, increases diagnostic precision. This is in line with a study of screening for depression with Mood and Feelings Questionnaire (MFQ), where a combination of parent and patient ratings was better than either rating alone [48]. When data has been analyzed separately across gender, it shows a significant contribution for adding parent ratings for adolescent girls but surprisingly not for boys [19], which would be important to examine further.

However, adding the child as the informant to information from parents does not increase diagnostic efficiency for the ODD and OCD DOSs, which corresponds to the findings of the ROC analyses. In addition, adding the parental information for CD DOS to information from the child does not increase diagnostic efficiency while for CD adding the child as an informant to the parent increases the diagnostic efficiency. This is not surprising as parents do not always have full knowledge about disruptive behaviors for adolescents.

The results also revealed that boys scored significantly higher on the CBCL ADHD. We did not find any gender differences in other CBCL DOS. Parents ratings for depression and anxiety were similar across gender while girls´ ratings were higher, which is in line with our findings from the Mood and Feelings Questionnaire (MFQ) [19] and Screen for Child Anxiety Related Emotional Disorders [18]. Our MFQ study also showed that parents and girls´ report correlated highly. However, the girls scored consequently higher, suggesting that girls express affective symptoms more markedly [19].

Strengths and limitations

The main strength of this study was the large sample of participants from a specialized CAP clinical population. All patients were new referrals without prior contact with psychiatric services. Thus, they had not received any prior psychiatric diagnosis, assessment or psychoeducation. This recruitment is ecologically suitable for testing the screening efficiency of the CBCL/YSR ahead of receiving a diagnosis. LEAD diagnoses were high quality, as they were based both on a semi-structured interview and on further clinical work-up and observations as well as expert consensus by two senior consultants (TI and HJ). The expert consensus work was independent of the ASEBA scores, as no information from the scales was included in the clinical records. There were adequate numbers for ADHD (n = 60), anxiety disorders (n = 48) and depression (n = 61) on the YSR self-report for analyzing concurrent and incremental validity of the DOSs.

However, there were some limitations as well. First, although this was a sizable study, the number of patients in some diagnostic groups was small. For instance, we had only 11 participants with CD and 12 with OCD limiting our analysis strategy, especially for convergent and divergent validity using logistic regression. Second, using LEAD diagnoses based on enhancing K-SADS with information from clinical records is still at risk of including spurious variation.

Conclusion

In a child and adolescent outpatient psychiatric setting, the subscales of CBCL and YSR for ADHD, anxiety disorders, depression, and conduct disorders and the CBCL subscales for ODD and OCD can be used for screening or for enhancing diagnostic assessment. Adding self-report to parent-report and vice versa improves the prediction and is recommended for youths. YSR self-report for OCD and ODD should not be used.

Supporting information

S1 File

(DOCX)

S1 Data

(SAV)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

HJ, 2008-22893, Stiftelsen Söderström-Königska, https://www.sls.se/vetenskap/sok-anslag/stift.-soderstrom/, NO role in design, data, publishing, preparation MA, 110361, Development and Education (FoUU) within Region Halland, Sweden, https://vardgivare.regionhalland.se/utveckling-forskning/forskning/projektmedel-och-bidrag-for-forskning-och-utveckling/doktorandmedel/, NO role in design, data, publishing, preparation HJ, 133821, Development and Education (FoU) within Region Skåne, Sweden, https://www.skane.se/organisation-politik/forskning/sa-finansierar-vi-forskningen/, NO role in design, data, publishing, preparation.

References

  • 1.Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA (2015) Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. Journal of child psychology and psychiatry, and allied disciplines 56: 345–365. doi: 10.1111/jcpp.12381 [DOI] [PubMed] [Google Scholar]
  • 2.Merikangas KR, Nakamura EF, Kessler RC (2009) Epidemiology of mental disorders in children and adolescents. Dialogues in Clinical Neuroscience 11: 7–20. doi: 10.31887/DCNS.2009.11.1/krmerikangas [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Belfer ML (2008) Child and adolescent mental disorders: the magnitude of the problem across the globe. J Child Psychol Psychiatry 49: 226–236. doi: 10.1111/j.1469-7610.2007.01855.x [DOI] [PubMed] [Google Scholar]
  • 4.Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B, group CS et al. (2012) The economic cost of brain disorders in Europe. European Journal of Neurology 19: 155–162. doi: 10.1111/j.1468-1331.2011.03590.x [DOI] [PubMed] [Google Scholar]
  • 5.Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L et al. (2010) Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication—Adolescent Supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry 49: 980–989. doi: 10.1016/j.jaac.2010.05.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hansen BH, Oerbeck B, Skirbekk B, Kristensen H (2016) Non-obsessive-compulsive anxiety disorders in child and adolescent mental health services—Are they underdiagnosed, and how accurate is referral information? Nordic Journal of Psychiatry 70: 133–139. doi: 10.3109/08039488.2015.1061053 [DOI] [PubMed] [Google Scholar]
  • 7.Gren-Landell M, Aho N, Carlsson E, Jones A, Svedin CG (2013) Posttraumatic stress symptoms and mental health services utilization in adolescents with social anxiety disorder and experiences of victimization. Eur Child Adolesc Psychiatry 22: 177–184. doi: 10.1007/s00787-012-0336-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Heiervang E, Stormark KM, Lundervold AJ, Heimann M, Goodman R, Posserud MB et al. (2007) Psychiatric disorders in Norwegian 8- to 10-year-olds: an epidemiological survey of prevalence, risk factors, and service use. Journal of the American Academy of Child and Adolescent Psychiatry 46: 438–447. doi: 10.1097/chi.0b013e31803062bf [DOI] [PubMed] [Google Scholar]
  • 9.Heyman I, Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R (2001) Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. British Journal of Psychiatry 179: 324–329. doi: 10.1192/bjp.179.4.324 [DOI] [PubMed] [Google Scholar]
  • 10.Rasmussen SA, Eisen JL (1992) The epidemiology and clinical features of obsessive compulsive disorder. Psychiatric Clinics of North America 15: 743–758. [PubMed] [Google Scholar]
  • 11.Pignone MP, Gaynes BN, Rushton JL, Burchell CM, Orleans CT, Mulrow CD et al. (2002) Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 136: 765–776. doi: 10.7326/0003-4819-136-10-200205210-00013 [DOI] [PubMed] [Google Scholar]
  • 12.Jarbin H, Andersson M, Rastam M, Ivarsson T (2017) Predictive validity of the K-SADS-PL 2009 version in school-aged and adolescent outpatients. Nordic Journal of Psychiatry 71: 270–276. doi: 10.1080/08039488.2016.1276622 [DOI] [PubMed] [Google Scholar]
  • 13.Youngstrom EA, Choukas-Bradley S, Calhoun CD, Jensen-Doss A (2015) Clinical Guide to the Evidence-Based Assessment Approach to Diagnosis and Treatment. Cognitive and Behavioral Practice 22: 20–35. [Google Scholar]
  • 14.Youngstrom EA (2014) A primer on receiver operating characteristic analysis and diagnostic efficiency statistics for pediatric psychology: we are ready to ROC. Journal of Pediatric Psychology 39: 204–221. doi: 10.1093/jpepsy/jst062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kraemer H (1992) Evaluating Medical Tests: Objective and quantitative guidelines. Thousand Oaks, CA: Sage Publications. [Google Scholar]
  • 16.Achenbach TM, McConaughy SH, Howell CT (1987) Child/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity. Psychological Bulletin 101: 213–232. [PubMed] [Google Scholar]
  • 17.De Los Reyes A, Augenstein TM, Wang M, Thomas SA, Drabick DA, Burgers DE et al. (2015) The validity of the multi-informant approach to assessing child and adolescent mental health. Psychological Bulletin 141: 858–900. doi: 10.1037/a0038498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ivarsson T, Skarphedinsson G, Andersson M, Jarbin H (2017) The Validity of the Screen for Child Anxiety Related Emotional Disorders Revised (SCARED-R) Scale and Sub-Scales in Swedish Youth. Child Psychiatry and Human Development [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Jarbin H, Ivarsson T, Andersson M, Bergman H, Skarphedinsson G (2020) Screening efficiency of the Mood and Feelings Questionnaire (MFQ) and Short Mood and Feelings Questionnaire (SMFQ) in Swedish help seeking outpatients. PLOS ONE 15: e0230623. doi: 10.1371/journal.pone.0230623 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Jensen PS, Rubio-Stipec M, Canino G, Bird HR, Dulcan MK, Schwab-Stone ME et al. (1999) Parent and Child Contributions to Diagnosis of Mental Disorder: Are Both Informants Always Necessary? Journal of the American Academy of Child and Adolescent Psychiatry 38: 1569–1579. doi: 10.1097/00004583-199912000-00019 [DOI] [PubMed] [Google Scholar]
  • 21.Pelham J, William E., Fabiano GA, Massetti GM (2005) Evidence-Based Assessment of Attention Deficit Hyperactivity Disorder in Children and Adolescents. Journal of Clinical Child & Adolescent Psychology 34: 449–476. doi: 10.1207/s15374424jccp3403_5 [DOI] [PubMed] [Google Scholar]
  • 22.Comer JS, Kendall PC (2004) A symptom-level examination of parent-child agreement in the diagnosis of anxious youths. J Am Acad Child Adolesc Psychiatry 43: 878–886. doi: 10.1097/01.chi.0000125092.35109.c5 [DOI] [PubMed] [Google Scholar]
  • 23.Cosi S, Canals J, Hernández-Martinez C, Vigil-Colet A (2010) Parent-child agreement in SCARED and its relationship to anxiety symptoms. J Anxiety Disord 24: 129–133. doi: 10.1016/j.janxdis.2009.09.008 [DOI] [PubMed] [Google Scholar]
  • 24.Achenbach TM, Rescorla LA (2001) Manual for the ASEBA School-Age Forms & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, and Families. [Google Scholar]
  • 25.Brunshaw JM, Szatmari P (1988) The Agreement between Behaviour Checklists and Structured Psychiatric Interviews for Children. The Canadian Journal of Psychiatry 33: 474–481. doi: 10.1177/070674378803300608 [DOI] [PubMed] [Google Scholar]
  • 26.Jensen PS, Salzberg AD, Richters JE, Watanabe HK (1993) Scales, Diagnoses, and Child Psychopathology: I. CBCL and DISC Relationships. Journal of the American Academy of Child and Adolescent Psychiatry 32: 397–406. doi: 10.1097/00004583-199303000-00022 [DOI] [PubMed] [Google Scholar]
  • 27.Kasius MC, Ferdinand RF, Berg H, Verhulst FC (2006) Associations between Different Diagnostic Approaches for Child and Adolescent Psychopathology. Journal of Child Psychology and Psychiatry 38: 625–632. [DOI] [PubMed] [Google Scholar]
  • 28.Van Meter A, Youngstrom E, Youngstrom JK, Ollendick T, Demeter C, Findling RL (2014) Clinical decision making about child and adolescent anxiety disorders using the Achenbach system of empirically based assessment. Journal of Clinical Child and Adolescent Psychology 43: 552–565. doi: 10.1080/15374416.2014.883930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Ebesutani C, Bernstein A, Nakamura BJ, Chorpita BF, Higa-McMillan CK, Weisz JR (2010) Concurrent Validity of the Child Behavior Checklist DSM-Oriented Scales: Correspondence with DSM Diagnoses and Comparison to Syndrome Scales. Journal of Psychopathology and Behavioral Assessment 32: 373–384. doi: 10.1007/s10862-009-9174-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ebesutani C, Bernstein A, Martinez JI, Chorpita BF, Weisz JR (2011) The youth self report: applicability and validity across younger and older youths. Journal of Clinical Child and Adolescent Psychology 40: 338–346. doi: 10.1080/15374416.2011.546041 [DOI] [PubMed] [Google Scholar]
  • 31.Bellina M, Brambilla P, Garzitto M, Negri GAL, Molteni M, Nobile M (2013) The ability of CBCL DSM-oriented scales to predict DSM-IV diagnoses in a referred sample of children and adolescents. European Child and Adolescent Psychiatry 22: 235–246. doi: 10.1007/s00787-012-0343-0 [DOI] [PubMed] [Google Scholar]
  • 32.Aebi M, Winkler Metzke C, Steinhausen H-C (2010) Accuracy of the DSM-Oriented Attention Problem Scale of the Child Behavior Checklist in Diagnosing Attention-Deficit Hyperactivity Disorder. Journal of Attention Disorders 13: 454–463. doi: 10.1177/1087054708325739 [DOI] [PubMed] [Google Scholar]
  • 33.Dingle K, Alati R, Williams GM, Najman JM, Bor W, Clavarino A (2010) The ability of YSR DSM-oriented depression scales to predict DSM-IV depression in young adults: a longitudinal study. Journal of Affective Disorders 121: 45–51. doi: 10.1016/j.jad.2009.05.013 [DOI] [PubMed] [Google Scholar]
  • 34.Ferdinand RF (2008) Validity of the CBCL/YSR DSM-IV scales Anxiety Problems and Affective Problems. Journal of Anxiety Disorders 22: 126–134. doi: 10.1016/j.janxdis.2007.01.008 [DOI] [PubMed] [Google Scholar]
  • 35.Lacalle M, Ezpeleta L, Domenech JM (2012) DSM-Oriented Scales of the Child Behavior Checklist and Youth Self-Report in clinically referred Spanish children. Spanish Journal of Psychology 15: 377–387. doi: 10.5209/rev_sjop.2012.v15.n1.37344 [DOI] [PubMed] [Google Scholar]
  • 36.Cianchetti C, Faedda N, Pasculli M, Ledda MG, Diaz G, Peschechera A et al. (2020) Predictive validity for the clinical diagnosis of a new parent questionnaire, the CABI, compared with CBCL. Clin Child Psychol Psychiatry 25: 507–519. doi: 10.1177/1359104519895056 [DOI] [PubMed] [Google Scholar]
  • 37.Ivarsson T, Larsson B (2008) The Obsessive-Compulsive Symptom (OCS) scale of the Child Behavior Checklist: a comparison between Swedish children with Obsessive-Compulsive Disorder from a specialized unit, regular outpatients and a school sample. Journal of Anxiety Disorders 22: 1172–1179. doi: 10.1016/j.janxdis.2007.12.004 [DOI] [PubMed] [Google Scholar]
  • 38.Nelson EC, Hanna GL, Hudziak JJ, Botteron KN, Heath AC, Todd RD (2001) Obsessive-compulsive scale of the child behavior checklist: specificity, sensitivity, and predictive power. Pediatrics 108: E14. doi: 10.1542/peds.108.1.e14 [DOI] [PubMed] [Google Scholar]
  • 39.Spitzer RL (1983) Psychiatric diagnosis: are clinicians still necessary? Comprehensive Psychiatry 24: 399–411. doi: 10.1016/0010-440x(83)90032-9 [DOI] [PubMed] [Google Scholar]
  • 40.Young JG, O’Brien JD, Gutterman EM, Cohen P (1987) Research on the clinical interview. Journal of the American Academy of Child and Adolescent Psychiatry 26: 613–620. doi: 10.1097/00004583-198709000-00002 [DOI] [PubMed] [Google Scholar]
  • 41.Kranzler HR, Kadden RM, Babor TF, Rounsaville BJ (1994) Longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders. Journal of Nervous and Mental Disease 182: 277–283. doi: 10.1097/00005053-199405000-00005 [DOI] [PubMed] [Google Scholar]
  • 42.Kranzler HR, Tennen H, Babor TF, Kadden RM, Rounsaville BJ (1997) Validity of the longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders. Drug and Alcohol Dependence 45: 93–104. doi: 10.1016/s0376-8716(97)01349-5 [DOI] [PubMed] [Google Scholar]
  • 43.Swets JA (1982) Sensitivities and specificities of diagnostic tests. JAMA 248: 548–549. [PubMed] [Google Scholar]
  • 44.Swets JA (1988) Measuring the accuracy of diagnostic systems. Science 240: 1285. doi: 10.1126/science.3287615 [DOI] [PubMed] [Google Scholar]
  • 45.Spitzer RL, Fleiss JL, Endicott J (1978) Reliability and Validity. In: Lipton MA, DiMascio A, Killiam K, editors. Psychopharmacology: A generation of progress. New York: Raven Press. pp. 857–869. [Google Scholar]
  • 46.Vreugdenhil C, van den Brink W, Ferdinand R, Wouters L, Doreleijers T (2006) The ability of YSR scales to predict DSM/DISC-C psychiatric disorders among incarcerated male adolescents. European Child and Adolescent Psychiatry 15: 88–96. doi: 10.1007/s00787-006-0497-8 [DOI] [PubMed] [Google Scholar]
  • 47.Storch EA, Park JM, Lewin AB, Morgan JR, Jones AM, Murphy TK (2011) The Leyton Obsessional Inventory-Child Version Survey Form does not demonstrate adequate psychometric properties in American youth with pediatric obsessive-compulsive disorder. Journal of Anxiety Disorders [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Daviss WB, Birmaher B, Melhem NA, Axelson DA, Michaels SM, Brent DA (2006) Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects. Journal of Child Psychology and Psychiatry and Allied Disciplines 47: 927–934. doi: 10.1111/j.1469-7610.2006.01646.x [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Thomas M Olino

26 May 2021

PONE-D-21-10635

Diagnostic efficiency and validity of the DSM-oriented Child Behavior Checklist and Youth Self-Report scales in a clinical sample of Swedish youth

PLOS ONE

Dear Dr. Skarphedinsson,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I was hoping to receive a second review of your work, but, unfortunately, it has not been received. I thank the reviewer for their attention to the manuscript. You will see that the reviewer noted a number of clarifications for your work. I concur with the reviewer that the work is done well. The supplementary material, particularly the tables showing the full set of AUC values across scale cutoff values was very helpful. However, I have some additional queries and comments that are intended to help move the work along.

The motivation for the work on the use of the DSM oriented scale (DOS) scores and diagnostic specificity is clear. However, there could be some additional details about the motivation to rely on youth and maternal reports, rather than other selection of informants.

In the initial paragraph of the Methods, you note: “The observation time that yielded new diagnostic information was 1.2 (SD 0.6) years with a range of 0.1–3.1 years.” It is not clear, at this point in the manuscript, what this information is about. Is this about using the LEAD process? If so, this should be integrated into the description.

Table 2 presents DOS between youth with and without diagnoses and between male and female youth. However, the comparisons of male and female youth are not motivated in the introduction or commented on in the Discussion. You have a choice in how to handle the inclusion/exclusion of these analyses. Please justify your decision; if these are retained be sure to justify their inclusion in the manuscript.

Tables 2 & 3 show associations between DOS scores and diagnoses as mean differences and AUC, respectively. These appear to be reparametrized estimates of the same quantity. Please describe how these are different. Moreover, it was not clear whether the models estimated in Table 4 included only a single predictor in each model. If so, then these ORs would be a third representation of the same information. Please clarify whether the models in Table 4 include one or more predictors in the same model.

In the models where youth report was added to parent report, in that order, were parent reports only included if they also had youth reports? If not, then the model R2 for the initial step would be based on different data than the model with both informants.

In the Discussion, some results are described as if there were direct tests of differences in magnitudes of association. However, the analyses, as presently communicated, are only showing whether there were significant or non-significant associations between DOS scores and diagnoses. This language should be addressed.

Please submit your revised manuscript by Jul 08 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Thomas M. Olino

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables should remain uploaded as separate "supporting information" files.

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

4. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

- https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0230623

- https://link.springer.com/article/10.1007%2Fs10578-017-0746-8

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a study on the clinical properties of CBCL, with an excellent experimental design and an advanced analysis of the collected data. It is probably the most accurate CBCL study to date.

The CBCL is a widely used tool, with very high number of citations on PubMed, but there are not many studies on its clinical properties in relation to scaling according to DSM criteria. In the introduction (second page) the authors report these studies; probably for completeness it is appropriate to add the most recent published in Clin Child Psychol Psychiatry 2020;25:507-519. doi: 10.1177/1359104519895056.

The clinical analysis is particularly accurate according to the criteria of the Longitudinal Expert All Data (LEAD) procedure, even if, considering the variability over time of the clinical picture in children and adolescents, it is questionable whether a final evaluation at an average distance of many months may sometimes not exactly correspond to the clinical situation at the time of administration of the CBCL

In the "Diagnostic efficiency" section there is a repetition relating to YSR ODD and OCD.

In the “Concurrent and discriminant validity” section, please check what is written in relation to the YSR (last lines) in relation to the data in table 4.

As for the incremental validity, I wonder if adding CBCL to YSR and vice versa can increase the accuracy of that of the two which is already more accurate.

Some minor corrections in the tables.

Table 2 gender t-test YSR ODD -9.360 (probably wrong)

Decimal separator: sometimes is comma instead of dot.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jul 22;16(7):e0254953. doi: 10.1371/journal.pone.0254953.r002

Author response to Decision Letter 0


30 Jun 2021

Diagnostic efficiency and validity of the DSM-oriented Child Behavior Checklist and Youth Self-Report scales in a clinical sample of Swedish youth

Authors´responses to reviews

Editor

I was hoping to receive a second review of your work, but, unfortunately, it has not been received. I thank the reviewer for their attention to the manuscript. You will see that the reviewer noted a number of clarifications for your work. I concur with the reviewer that the work is done well. The supplementary material, particularly the tables showing the full set of AUC values across scale cutoff values was very helpful. However, I have some additional queries and comments that are intended to help move the work along.

Authors‘ response

Thank you.

Editor

The motivation for the work on the use of the DSM oriented scale (DOS) scores and diagnostic specificity is clear.

However, there could be some additional details about the motivation to rely on youth and maternal reports, rather than other selection of informants.

Authors‘ response

Unfortunately, we only had access to youth and maternal reports. However, we acknowledge that it is a strength to add an additional informant such as father or teacher.

Editor

In the initial paragraph of the Methods, you note: “The observation time that yielded new diagnostic information was 1.2 (SD 0.6) years with a range of 0.1–3.1 years.” It is not clear, at this point in the manuscript, what this information is about. Is this about using the LEAD process? If so, this should be integrated into the description.

Authors‘ response

Thank you. We have moved this sentence to the measures and procedures section where the LEAD process is described.

Editor

Table 2 presents DOS between youth with and without diagnoses and between male and female youth. However, the comparisons of male and female youth are not motivated in the introduction or commented on in the Discussion. You have a choice in how to handle the inclusion/exclusion of these analyses. Please justify your decision; if these are retained be sure to justify their inclusion in the manuscript.

Authors‘ response

Thank you.

We have added a sentence in the aim section

„by comparing diagnosis-specific DOS scores between children with and without the diagnosis-specific disorder“.

and

„Our aim was also to examine potential gender differences in mean scores as discovered in our previous papers using same data {Ivarsson et al., 2017, #2921}{Jarbin et al., 2020, #5849}.“

We have also added a paragraph in the discussion

“The results also revealed that boys scored significantly higher on the CBCL ADHD. We did not find any gender differences in other CBCL DOS. Parents ratings for depression and anxiety were similar across gender while girls´ ratings were higher, which is in line with our findings from the Mood and Feelings Questionnaire (MFQ) {Jarbin et al., 2020, #5849} and Screen for Child Anxiety Related Emotional Disorders {Ivarsson et al., 2017, #2921}. Our MFQ study also showed that parents and girls´ report correlated highly. However, the girls scored consequently higher, suggesting that girls express affective symptoms more markedly {Jarbin et al., 2020, #5849}. “

Editor

Tables 2 & 3 show associations between DOS scores and diagnoses as mean differences and AUC, respectively. These appear to be reparametrized estimates of the same quantity. Please describe how these are different.

Authors‘ response

Thank you. We acknowledge that a part of table 2 (M and SD of diagnosis-specific disorder present/absent) is a reparameterization of table 3. However, we consider both tables to be valuable for our readers (clinicians and researchers). Table 2 added value is to compare M and SDs in this sample to clinical or community samples. Table 3 added value is to present AUCs and the most efficient cutoffs. Please, let us know if you need further elaboration or if changes are suggested.

Editor

Moreover, it was not clear whether the models estimated in Table 4 included only a single predictor in each model. If so, then these ORs would be a third representation of the same information. Please clarify whether the models in Table 4 include one or more predictors in the same model.

Authors‘ response

Thank you for noting that. We used multivariate logistic regression, all the DOS scales were used as independent variables in each model to determine the specific association between disorder (e.g., depression) and diagnosis-specific scale (e.g., CBCL depression). We apologize for this misunderstanding. We have added “multivariate” in the title. We have also added “multivariate” in statistical analysis and in the results section. We acknowledge that the univariate models are representations of the same information. however, we deem it important as it might be important for our readers to compare the ORs between the univariate and multivariate models.

Editor

In the models where youth report was added to parent report, in that order, were parent reports only included if they also had youth reports? If not, then the model R2 for the initial step would be based on different data than the model with both informants.

Authors‘ response

Thank you for noting that. Yes, we made sure to include only parent reports if they also had youth reports.

Editor

In the Discussion, some results are described as if there were direct tests of differences in magnitudes of association. However, the analyses, as presently communicated, are only showing whether there were significant or non-significant associations between DOS scores and diagnoses. This language should be addressed.

Authors‘ response

Thank you. Language is changed in Discussion, 2nd paragraph, line 6.

Editor

Please submit your revised manuscript by Jul 08 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Editor

Please include the following items when submitting your revised manuscript:

• A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

• A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

• An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Authors‘ response

(remember

(1) respones

(2) track changes

(3) CLEAN

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOSONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Thomas M. Olino

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOSONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdfand

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables should remain uploaded as separate "supporting information" files.

Authors‘ response

(Remember to add all tables to the Ms.)

3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Editor

4. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed:

- https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0230623

- https://link.springer.com/article/10.1007%2Fs10578-017-0746-8

In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed.

Authors‘ response

Thank you for noting that. We are the co-authors of both papers. We confirm that we only duplicated some parts of the method section.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

R1

Reviewer #1: This is a study on the clinical properties of CBCL, with an excellent experimental design and an advanced analysis of the collected data. It is probably the most accurate CBCL study to date.

The CBCL is a widely used tool, with very high number of citations on PubMed, but there are not many studies on its clinical properties in relation to scaling according to DSM criteria. In the introduction (second page) the authors report these studies; probably for completeness it is appropriate to add the most recent published in Clin Child Psychol Psychiatry 2020;25:507-519. doi: 10.1177/1359104519895056.

Authors‘ response

Thank you so much. We have added the study in our manuscript, when we list the studies that have examined the screening efficiency of the DOS depression, anxiety, ADHD, ODD, and CD. Great paper and interesting to read about the CABI.

R1

The clinical analysis is particularly accurate according to the criteria of the Longitudinal Expert All Data (LEAD) procedure, even if, considering the variability over time of the clinical picture in children and adolescents, it is questionable whether a final evaluation at an average distance of many months may sometimes not exactly correspond to the clinical situation at the time of administration of the CBCL

Authors‘ response

Thank you. We acknowledge, that LEAD diagnoses are not without problems when data over time is used. However, we want to cite the following paper (by the same research group): http://dx.doi.org/10.1080/08039488.2016.1276622. In this paper further description on our LEAD method can be accessed. the LEAD diagnoses were based on KSADS data and a minimum of three visits after the KSADS or of significant new information. KSADS diagnoses (at the time of intake) were compared to LEAD diagnoses. The results showed excellent agreement for most diagnoses. For instance, any depression kappa = 0.91, any anxiety disorders kappa = 0.94, any ADHD kappa 0.80. Among these diagnoses, the most notable information arriving after the KSADS-PL was information in rating scales and personal communication from teachers supporting a diagnosis of ADHD. Parents and patients were, at times, reducing their initial description of ADHD and functional impact but agreed later on when school had presented more support and they also were less reluctant of receiving the diagnosis. As ADHD has a chronic fluctuating course, we believe that the later additional information was valuable and correct. There were very few changes of affective diagnosis but in a rare case, the depression was covered by a panic disorder but elicited later on and clearly with an onset before the time of the CBCL/YSR.

R1

In the "Diagnostic efficiency" section there is a repetition relating to YSR ODD and OCD.

Authors‘ response

Thank you so much. We have changed accordingly by deleting the second sentence about ODD and OCD.

R1

In the “Concurrent and discriminant validity” section, please check what is written in relation to the YSR (last lines) in relation to the data in table 4.

Authors‘ response

Thank you again. We have modified the sentences according to the results in table 4.

R1

As for the incremental validity, I wonder if adding CBCL to YSR and vice versa can increase the accuracy of that of the two which is already more accurate.

Authors‘ response

Again, thank you. We understand that if we add CBCL DOS (e.g., depression) to YSR DOS (e.g., depression) the accuracy of predicting LEAD depression increases and vice versa. Yes, that´s exactly what happens :) if the delta (�) (i.e., increase in �2) is significant than adding CBCL to YSR and vice versa increases tha accuracy. Except for adding YSR ODD to CBCL ODD. Adding CBCL CD to YSR CD, and Adding YSR OCD to CBCL OCD.

R1

Some minor corrections in the tables.

Table 2 gender t-test YSR ODD -9.360 (probably wrong)

Authors‘ response

Wonderful, thank you so much for your sharp eyes. The correct t is 0.936. We missed one decimal.

R1

Decimal separator: sometimes is comma instead of dot.

Authors‘ response

Thank you and apologies. We have changed from comma to dot accordingly.

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOSat figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: ASEBA.Halmstad.responses.to.reviewers.docx

Decision Letter 1

Thomas M Olino

7 Jul 2021

Diagnostic efficiency and validity of the DSM-oriented Child Behavior Checklist and Youth Self-Report scales in a clinical sample of Swedish youth

PONE-D-21-10635R1

Dear Dr. Skarphedinsson,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Your responses were clear and the manuscript was clarified. 

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Thomas M. Olino

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Thomas M Olino

14 Jul 2021

PONE-D-21-10635R1

Diagnostic efficiency and validity of the DSM-oriented Child Behavior Checklist and Youth Self-Report scales in a clinical sample of Swedish youth

Dear Dr. Skarphedinsson:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Thomas M. Olino

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    S1 Data

    (SAV)

    Attachment

    Submitted filename: ASEBA.Halmstad.responses.to.reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES